Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (OTCQB:TTNP.PK)

0.705
Delayed Data
As of Aug 28
 +0.015 / +2.17%
Today’s Change
0.44
Today|||52-Week Range
0.99
+52.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.1M7.1M10.5M3.6M
 
 
 
 
 
Cost of Goods Sold11.2M0.00--0.00
 
 
Depreciation And Amortization32.0K17.0K107.0K353.0K
 
 
 
 
 
 
Operating ExpensesGross Income-7.1M7.1M--3.3M
 
 
 
 
General Expenses3.4M15.5M11.3M6.8M
 
 
 
 
 
Research And Development--10.6M8.3M4.1M
 
 
 
 
Total Operating Expenses14.6M15.5M11.4M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.5M-8.4M-891.0K-3.5M
 
 
 
 
 
Extraordinary Credit1.9M0.0012.6M1.1M
 
 
 
 
Extraordinary Charge0.00-1.8M0.000.00
 
 
Interest Expense On Debt6.4M4.9M1.6M--
 
 
 
 
Other Expenses-129.0K-183.0K-467.0K-11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.2M-15.2M9.7M-2.4M
 
 
 
 
 
Net Income-15.2M-15.2M9.7M-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.3M66.5M82.1M93.8M
 
 
 
 
 
Shares To Calculate EPS Diluted59.3M66.5M82.7M93.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.23$0.10-$0.04
 
 
 
 
 
EPS Diluted-$0.26-$0.23$0.10-$0.04